Cancer Diagnostics – Products

This application note outlines a comprehensive workflow for MRD detection, using a next-generation sequencing (NGS) approach to enable ultra-sensitive analysis with unmatched precision.

Thermo Fisher launches the Orbitrap Astral Zoom and Orbitrap Excedion Pro MS at ASMS 2025, advancing proteomics and drug development.

Explore how the 6-base genome, including 5mC and 5hmC, enables highly sensitive detection of stage 1 colorectal cancer and enhances prediction across disease stages. This study focuses on their roles as cfDNA biomarkers for early CRC detection.

PacBio enhances HiFi sequencing with AI-based methylation detection, enabling accurate native 5hmC and strand-specific 5mC analysis.

Biodesix, in partnership with Bio-Rad, contributed to the ctMoniTR Project, which demonstrated that changes in circulating tumor DNA (ctDNA) can predict cancer treatment outcomes.

This compendium provides researchers with a portfolio of electrophoresis instruments to support quality control and automation for a more reliable NGS workflow.

Ultima Genomics has launched the "Count on Us" initiative, offering 3 trillion DNA sequencing reads to researchers at academic, public or non-profit institutions in the U.S. and Canada.

This application note explores how electrophoretic methods surpass the capabilities of traditional methods to accurately distinguish between cfDNA and contaminating high molecular weight (HMW) DNA, making them ideal for cfDNA quality control.

Zymo Research celebrates a legal victory as the court denies QIAGEN’s motion in an ongoing antitrust and patent dispute.

Labor Dr. Wisplinghoff, and Genomic Testing Cooperative (GTC), are excited to announce the launch of their collaboration.